Metraipolis › archive › dc_ae2ffba61d8e

Myeloid-Derived Suppressor Cells in Cancer: Metabolic Reprogramming, Immune Crosstalk, and Therapeutic Targeting — Europe PMC PMID:42449692

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449692
DOI
10.3390/cancers18132150
License (as archived)
solo-consultazione
Archived
2026-10-18T11:27:49.930Z
SHA-256 of the archived text
d8d00a4915a026d4ed9fe0c592882355cd5ef11c09af76605240fe1eea9af7a0
Stable URL of this page
https://metraipolis.com/documento/dc_ae2ffba61d8e

How to cite

Myeloid-Derived Suppressor Cells in Cancer: Metabolic Reprogramming, Immune Crosstalk, and Therapeutic Targeting — Europe PMC PMID:42449692 — Europe PMC (en), https://europepmc.org/article/MED/42449692 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ae2ffba61d8e (Metraipolis archive dc_ae2ffba61d8e, sha256 d8d00a4915a026d4ed9fe0c592882355cd5ef11c09af76605240fe1eea9af7a0)
BibTeX
@misc{dcae2ffba61d8e,
  title = {Myeloid-Derived Suppressor Cells in Cancer: Metabolic Reprogramming, Immune Crosstalk, and Therapeutic Targeting — Europe PMC PMID:42449692},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449692},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ae2ffba61d8e; sha256 d8d00a4915a026d4ed9fe0c592882355cd5ef11c09af76605240fe1eea9af7a0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449692. Agents can read the archived copy with the MCP tool read_document.